Clinical Study of Caffeine for Apnea of Prematurity

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Apnea of Prematurity
Interventions
DRUG

NPC-11 for intravenous or oral administration.

NPC-11, Each vial (3mL) contains 60 mg caffeine citrate (equivalent to 30mg caffeine).

Trial Locations (3)

Unknown

Fujita Health University Hospital, Kutsukake

Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi

Tokyo Metropolitan Children's Medical Center, Fuchū

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nobelpharma

INDUSTRY